Endonuclease-responsive aptamer-functionalized hydrogel coating for sequential catch and release of cancer cells

Biomaterials

Volumn 34, Issue 2, 2013, Pages 460-469

  Li, Shihui ^a   Chen, Niancao ^a   Zhang, Zhaoyang ^a,b   Wang, Yong ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Affinity; Biocompatibility; Cell adhesion; Enzyme; Hydrogel; Interface

Indexed keywords

AFFINITY; APTAMER SEQUENCES; BIOMEDICAL DEVICES; CANCER CELLS; CELL BINDING; CIRCULATING TUMOR CELLS; COATING MATERIAL; HYDROGEL SURFACES; MEDICAL DEVICES; NON DESTRUCTIVE; RELEASE EFFICIENCY; RELEASED CELLS; RESTRICTION ENDONUCLEASES;

BIOCOMPATIBILITY; BIOMEDICAL EQUIPMENT; CELL ADHESION; CELLS; COATINGS; DIAGNOSIS; ENZYMES; INTERFACES (MATERIALS);

HYDROGELS;

ENDONUCLEASE; PEPTIDE APTAMER; POLYACRYLAMIDE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL CATCH AND RELEASE; CIRCULATING TUMOR CELL; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROGEL; HYDROLYSIS; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; SCANNING ELECTRON MICROSCOPY; SYNTHESIS;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELL LINE, TUMOR; CELL SEPARATION; DEOXYRIBONUCLEASE BAMHI; DNA RESTRICTION ENZYMES; GLASS; HUMANS; HYDROGEL; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; TRYPSIN;

EID: 84868211152     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.040     Document Type: Article

References (45)

1. Webster D.R., Sabbadini E. The prognostic significance of circulating tumour cells: a five-year follow-up study of patients with cancer of the breast. Can Med Assoc J 1967, 96:129-131.
2. Engel H., Kleespies C., Friedrich J., Breidenbach M., Kallenborn A., Schöndorf T., et al. Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics. Br J Cancer 1999, 81:1165-1173.
3. Ring A., Smith I.E., Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol 2004, 5:79-88.
4. Hogan B.V., Peter M.B., Shenoy H., Horgan K., Hughes T.A. Circulating tumour cells in breast cancer: prognostic indicators, metastatic intermediates, or irrelevant bystanders?. Mol Med Rep 2008, 1:775-779. [Review].
5. Krell J., Stebbing J. Circulating tumour cells as biomarkers in early breast cancer. Lancet Oncol 2012, 13:653-654.
6. Goeminne J.C., Guillaume T., Salmon M., Machiels J.P., D'Hondt V., Symann M. Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors. Bone Marrow Transplant 1999, 24:769-775.
7. Jung R., Krüger W., Hosch S., Holweg M., Kröger N., Gutensohn K., et al. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 1998, 78:1194-1198.
8. Brossart P., Schmier J.W., Krüger S., Willhauck M., Scheibenbogen C., Monier T., et al. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995, 55:4065-4068.
9. Sabbatini R., Federico M., Morselli M., Depenni R., Cagossi K., Luppi M., et al. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol 2000, 18:1914-1920.
10. Osborne M.P., Asina S., Wong G.Y., Old L.J., Cote R.J. Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system. Cancer Res 1989, 49:2510-2513.
11. Gross H.J., Verwer B., Houck D., Recktenwald D. Detection of rare cells at a frequency of one per million by flow-cytometry. Cytometry 1993, 14:519-526.
12. Brown M., Wittwer C. Flow cytometry: principles and clinical applications in hematology. Clin Chem 2000, 46:1221-1229.
13. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
14. Adams A.A., Okagbare P.I., Feng J., Hupert M.L., Patterson D., Göttert J., et al. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc 2008, 130:8633-8641.
15. Mayumi M., Sumimoto S.I., Kanazashi S.I., Hata D., Yamaoka K., Higaki Y., et al. Negative signaling in B cells by surface immunoglobulins. J Allergy Clin Immunol 1996, 98:S238-S247.
16. Smith J.A., Bluestone J.A. T cell inactivation and cytokine deviation promoted by anti-CD3 mAbs. Curr Opin Immunol 1997, 9:648-654.
17. Henke C., Bitterman P., Roongta U., Ingbar D., Polunovsky V. Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease. Am J Pathol 1996, 149:1639-1650.
18. El-Ali J., Sorger P.K., Jensen K.F. Cells on chips. Nature 2006, 442:403-411.
19. Reisewitz S., Schroeder H., Tort N., Edwards K.A., Baeummer A.J., Niemeyer C.M. Capture and culturing of living cells on microstructured DNA substrates. Biomed Mater 2010, 6:2162-2168.
20. Phillips J.A., Xu Y., Xia Z., Fan Z.H., Tan W.H. Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal Chem 2009, 81:1033-1039.
21. Wan Y., Kim Y., Li N., Cho S.K., Bachoo R., Ellington A.D., et al. Surface-immobilized aptamers for cancer cell isolation and microscopic cytology. Cancer Res 2010, 70:9371-9380.
22. Chen L., Liu X., Su B., Li J., Jiang L., Hang D., et al. Aptamer-mediated efficient capture and release of T lymphocytes on nanostructured surfaces. Adv Mater 2011, 23:4376-4380.
23. Plouffe B.D., Brown M.A., Iyer R.K., Radisic M., Murthy S.K. Controlled capture and release of cardiac fibroblasts using peptide-functionalized alginate gels in microfluidic channels. Lab Chip 2009, 9:1507-1510.
24. Soontornworajit B., Zhou J., Shaw M.T., Fan T.H., Wang Y. Hydrogel functionalization with DNA aptamers for sustained PDGF-BB release. Chem Commun 2010, 46:1857-1859.
25. Chen N., Zhang Z., Soontornworajit B., Zhou J., Wang Y. Cell adhesion on an artificial extracellular matrix using aptamer-functionalized PEG hydrogels. Biomaterials 2012, 33:1353-1362.
26. Zhu Z., Wu C., Liu H., Zou Y., Zhang X., Kang H., et al. An aptamer cross-linked hydrogel as a colorimetric platform for visual detection. Angew Chem Int Ed 2010, 49:1052-1056.
27. Banerjee I., Pangule R.C., Kane R.S. Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Adv Mater 2011, 23:690-718.
28. Harbers G.M., Emoto K., Greef C., Metzger S.W., Woodward H.N., Mascali J.J., et al. Functionalized poly(ethylene glycol)-based bioassay surface chemistry that facilitates bio-immobilization and inhibits nonspecific protein, bacterial, and mammalian cell adhesion. Chem Mater 2007, 19:4405-4414.
29. Yang C.Y., Huang L.Y., Shen T.L., Yeh J.A. Cell adhesion, morphology and biochemistry on nano-topographic oxidized silicon surfaces. Eur Cells Mater 2010, 20:415-430.
30. Kairdolf B.A., Mancini M.C., Smith A.M., Nie S.M. Minimizing nonspecific cellular binding of quantum dots with hydroxyl-derivatizied surface coatings. Anal Chem 2008, 80:3029-3034.
31. Lee M.H., Brass D.A., Morris R., Composto R.J., Ducheyne P. The effect of non-specific interactions on cellular adhesion using model surfaces. Biomaterials 2005, 26:1721-1730.
32. Uchida K., Otsuka H., Kaneko M., Kataoka K., Nagasaki Y. A reactive poly(ethylene glycol) layer to achieve specific surface plasmon resonance sensing with a high S/N ratio: the substantial role of a short underbrushed PEG layer in minimizing nonspecific adsorption. Anal Chem 2005, 77:1075-1080.
33. Senaratne W., Andruzzi L., Ober C.K. Self-assembled monolayers and polymer brushes in biotechnology: current applications and future perspectives. Biomacromolecules 2005, 6:2427-2448.
34. Cho W.K., Kong B., Choi I.S. Highly efficient non-biofouling coating of zwitterionic polymers: poly((3-(methacryloylamino)propyl)-dimethyl(3-sulfopropyl)ammonium hydroxide). Langmuir 2007, 23:5678-5682.
35. Jiang S., Cao Z. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv Mater 2009, 22:920-932.
36. Shangguan D., Li Y., Tang Z., Cao Z.C., Chen H.W., Mallikaratchy P., et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 2006, 103:11838-11843.
37. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
38. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
39. Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999, 45:1628-1650.
40. Hinsch B., Kula M.R. Physical and kinetic-properties of the site specific endonuclease BamHI from Bacillus amyloliquefaciens. Nucleic Acids Res 1980, 8:623-633.
41. Pingoud A., Jeltsch A. Recognition and cleavage of DNA by type-II restriction endonucleases. Eur J Biochem 1997, 246:1-22.
42. Venkatesh S., Wower J., Byrne M.E. Nucleic acid therapeutic carriers with on-demand triggered release. Bioconjug Chem 2009, 20:1773-1782.
43. Dexter D.L., Kowalski H.M., Blazar B.A., Fligiel Z., Vogel R., Heppner G.H. Heterogeneity of tumor-cells from a single mouse mammary tumor. Cancer Res 1978, 38:3174-3181.
44. Fargion S., Carney D., Mulshine J., Rosen S., Bunn P., Jewett P., et al. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res 1986, 46:2633-2638.
45. Poste G., Tzeng J., Doll J., Breig R., Rieman D., Zeidman I. Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc Natl Acad Sci U S A 1982, 79:6574-6578.